Maitalon 20

Drospirenone, the active ingredient in Maitalon 20, is a combined oral contraceptive presented as a tablet for oral use. It is indicated for contraception and for regulation of menstrual cycles in women of reproductive age. GNH USA supplies Maitalon 20 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maitalon 20, a combined oral contraceptive, is used within the reproductive health pathway to prevent pregnancy and to manage menstrual timing. - Contraception: provides reliable prevention of pregnancy when taken as prescribed. - Regulation of menstrual cycles: helps achieve predictable, regular bleeding patterns. - Hormonal cycle control: reduces menstrual irregularities and associated discomfort.

Maitalon 20 may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: occasional stomach upset, often improves with continued use. - Headache: mild to moderate tension‑type headaches. - Breast tenderness: temporary swelling or discomfort. - Spotting: irregular light bleeding between periods.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins, requiring immediate medical attention. - Stroke: rare cerebrovascular event, especially in high‑risk individuals. - Liver tumor: extremely uncommon hepatic neoplasm.

Before prescribing Maitalon 20, clinicians should evaluate individual risk factors and counsel patients on safe use. - Cardiovascular assessment: avoid in women with history of thromboembolic disease or uncontrolled hypertension. - Liver function review: contraindicated in severe hepatic impairment. - Smoking status: do not prescribe to smokers over 35 years of age. - Drug interaction check: verify concomitant medications that may reduce efficacy. - Missed tablet guidance: provide clear instructions for handling missed doses. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Maitalon 20 can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Rifampin: strong CYP3A4 inducer that reduces contraceptive hormone levels. - Carbamazepine: enzyme inducer that may compromise efficacy. - St. John’s wort: herbal inducer that can lower plasma concentrations.

Moderate Interactions (Monitor Closely): - Ketoconazole: antifungal that can increase hormone exposure. - HIV protease inhibitors: may elevate hormone levels, requiring monitoring. - Selective serotonin reuptake inhibitors (SSRIs): can affect bleeding patterns and require observation.